Brief: Merit Medical’s Wrapsody Arteriovenous Access Efficacy Pivotal Study Completes Enrollment

Merit Medical Systems

03/08/2023 14:33

Aug 3 (Reuters) - Merit Medical Systems Inc  MMSI.O :
    * MERIT MEDICAL’S WRAPSODY™ ARTERIOVENOUS ACCESS EFFICACY
(WAVE)
PIVOTAL STUDY COMPLETES ENROLLMENT
    * MERIT MEDICAL SYSTEMS INC - INTENDS TO COLLECT SAFETY AND
EFFICACY OUTCOMES THROUGHOUT STUDY FOLLOW-UP PERIOD
    * MERIT MEDICAL SYSTEMS - ANTICIPATES FILING PRIMARY
OUTCOMES WITH
U.S. FDA FOR PREMARKET APPROVAL AFTER SIX MONTHS POST-ENROLLMENT
COMPLETION
    * MERIT MEDICAL SYSTEMS INC - INTENDS TO FOLLOW PATIENTS
ENROLLED
IN WAVE STUDY FOR 24 MONTHS FOLLOWING COMPLETION OF ENROLLMENT

Source text for Eikon:  ID:nGNXbG106p 
Further company coverage:  MMSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))